Newsletter

Weekly Updates on the Latest in Women's Health

Midlife EndometriosisWorkplace BenefitsSexual HealthPerimenopause & MenopausePainBreaking TaboosUterine FibroidsPelvic HealthReproductive YearsPregnancy & MotherhoodHysterectomyNewsletterFertility/Trying to ConceiveMental HealthPCOSNews and DataGeneral HealthBlogFemale CancerNew BookYear in ReviewThyroid DiseaseAutoimmune & Chronic DiseaseHormones and Menstrual HealthParticipate in Research
Midlife Midlife
+4+4
From ADHD to Action: Women’s Health Is Finally Getting Personal

From ADHD to Action: Women’s Health Is Finally Getting Personal

Policy. Advocacy. Mental health. From global change to daily realities, women’s health is evolving—and this week shows how.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+6+6
When Science, Policy & Women’s Lives Collide

When Science, Policy & Women’s Lives Collide

From FDA hearings on menopause to breakthroughs reshaping women’s health, this week’s stories reveal how data, art, and advocacy are rewriting the narrative.

Georgie Kovacs
Georgie Kovacs
Reproductive YearsReproductive Years
+3+3
When Labels Lag: Depo-Provera Lawsuit, 2 Events + Roundup

When Labels Lag: Depo-Provera Lawsuit, 2 Events + Roundup

Post-market signals should move from studies → labels → EHRs → patient alerts. Inside: PMDD webinar, WH Horizons, FDA vaginal estrogen, IVF robotics.

Georgie Kovacs
Georgie Kovacs
Breaking TaboosBreaking Taboos
+1+1
👉 AI Won’t Fix Healthcare If It Ignores Women

👉 AI Won’t Fix Healthcare If It Ignores Women

Why women’s health data gaps put us at risk — and how AI could help if we get it right.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+9+9
Pain, Policy & the Future of Women’s Health

Pain, Policy & the Future of Women’s Health

Chronic pain stories, FDA menopause deadline, this month’s top reads—and a sneak peek at AI in women’s health.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+5+5
$100M Won’t Fix Women’s Health

$100M Won’t Fix Women’s Health

Joanna Strober shares what philanthropy, venture, and culture reveal about the scale of change women really need.

Georgie Kovacs
Georgie Kovacs
NewsletterNewsletter
+1+1
Australia Has a Dashboard. The UK Has a Plan. What About the US?

Australia Has a Dashboard. The UK Has a Plan. What About the US?

Inside: global women’s health strategies, new BP guidelines, GSM innovation, and upcoming expert interviews you won’t want to miss.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+5+5
Longevity Isn’t Biohacking: What Women Need to Know About Living Well, Longer

Longevity Isn’t Biohacking: What Women Need to Know About Living Well, Longer

Sports scientist Roma van der Walt explains why healthspan matters more than lifespan — and how wearables, prevention, and AI are reshaping women’s health.

Georgie Kovacs
Georgie Kovacs
Midlife Midlife
+3+3
GLP-1 Drugs, Sex Differences & Side Effects

GLP-1 Drugs, Sex Differences & Side Effects

Why women face higher risks on Ozempic and Wegovy — plus AI in medicine, iron deficiency gaslighting, and tools changing safety and care.

Georgie Kovacs
Georgie Kovacs
EndometriosisEndometriosis
+4+4
From AI to Endo: What’s Shaping Women’s Health Now

From AI to Endo: What’s Shaping Women’s Health Now

Censorship, groundbreaking studies, and the tech shaping our future — all in this week’s issue.

Georgie Kovacs
Georgie Kovacs
EndometriosisEndometriosis
+5+5
From $2.5B in Women’s Health Funding to the Cervix’s Secrets

From $2.5B in Women’s Health Funding to the Cervix’s Secrets

Longevity breakthroughs, new cervical research, autism myths, and why training with your cycle is making a comeback.

Georgie Kovacs
Georgie Kovacs
Uterine FibroidsUterine Fibroids
+5+5
Who Gets to Decide? Power, Pills & the Politics of Women’s Health

Who Gets to Decide? Power, Pills & the Politics of Women’s Health

From fibroids to antidepressants in pregnancy, we’re unpacking the choices women think they have—and what they’re not being told.

Georgie Kovacs
Georgie Kovacs